| Typicality: | 0.370 |
| Saliency: | 0.335 |
| in the united states | 7 | location |
| currently | 3 | temporal |
| mostly | 2 | degree |
| drug → be → unapproved | 32 |
| drug → be unapproved by → the fda | 5 |
| negative | neutral | positive |
| 0.558 | 0.368 | 0.074 |
| Raw frequency | 37 |
| Normalized frequency | 0.335 |
| Modifier score | 0.700 |
| Perplexity | 44.556 |